{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:34:35Z","timestamp":1787495675981,"version":"build-2736575974"},"reference-count":31,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T00:00:00Z","timestamp":1768521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacy Practice"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:p>\n                    <jats:bold>Background:<\/jats:bold>\n                    Patients receiving mechanical circulatory support (MCS) devices should receive anticoagulation to avoid clotting of the circuit and to lower risk of acute thrombosis. Patients at our institution are initiated on UFH at 12\u00a0units\/kg\/h; however, patients weighing &gt; 83\u00a0kg are weight-capped (WC) at an initial rate of 1000\u00a0units\/h, which equates to &lt; 12\u00a0units\/kg\/h.\n                    <jats:bold>Objective:<\/jats:bold>\n                    The objective of this study was to compare time to goal anticoagulation in patients receiving MCS who were WC compared to those who were not.\n                    <jats:bold>Methods:<\/jats:bold>\n                    A retrospective cohort study was completed of patients who received UFH during admission for an MCS device and monitored by activated partial thromboplastin time (aPTT) or anti-Xa levels. The primary outcome was the percentage of patients between groups who achieved goal anti-Xa or aPTT within 48\u00a0h of UFH initiation.\n                    <jats:bold>Results:<\/jats:bold>\n                    A total of 56 patients were included, with 27 not weight-capped (NWC) and 29 WC. There was no significant difference between groups in percentage of patients who achieved goal anti-Xa or aPTT within 48\u00a0h (88.9% NWC vs 89.7% WC,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.93). There was no significant difference in time to goal between groups. The NWC group had more bleeding events (4 vs 0,\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.031), with no difference in thrombosis.\n                    <jats:bold>Conclusion:<\/jats:bold>\n                    There was no difference in the percentage of patients reaching goal aPTT or anti-Xa within 48\u00a0h when UFH was WC. However, future studies should compare differences in time to goal anticoagulation between different UFH intensity protocols.\n                  <\/jats:p>","DOI":"10.1177\/08971900261417915","type":"journal-article","created":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T00:06:39Z","timestamp":1768608399000},"page":"424-431","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Initial Heparin Rates on Reaching Goal Anti-Xa and Activated Partial Thromboplastin Time Within 48 Hours of Initiation in Patients With Mechanical Circulatory Support"],"prefix":"10.1177","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7365-3678","authenticated-orcid":false,"given":"Jordan","family":"Orchard","sequence":"first","affiliation":[{"name":"OhioHealth Riverside Methodist Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-6329","authenticated-orcid":false,"given":"Erica","family":"Caffarini","sequence":"additional","affiliation":[{"name":"OhioHealth Riverside Methodist Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6795-8619","authenticated-orcid":false,"given":"Angela","family":"Harding","sequence":"additional","affiliation":[{"name":"OhioHealth Riverside Methodist Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Schuler","sequence":"additional","affiliation":[{"name":"OhioHealth Riverside Methodist Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie M.","family":"Lockhart","sequence":"additional","affiliation":[{"name":"OhioHealth Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Dillis","sequence":"additional","affiliation":[{"name":"OhioHealth Research Institute"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8071-0226","authenticated-orcid":false,"given":"Alyssa","family":"Meester","sequence":"additional","affiliation":[{"name":"OhioHealth Riverside Methodist Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"e_1_3_7_2_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-024-01260-y"},{"key":"e_1_3_7_3_2","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.13341021"},{"key":"e_1_3_7_4_2","doi-asserted-by":"publisher","DOI":"10.17925\/HI.2022.16.1.37"},{"issue":"18","key":"e_1_3_7_5_2","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich PA","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2022;145(18):e895-e1032.","journal-title":"Circulation"},{"key":"e_1_3_7_6_2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab368"},{"key":"e_1_3_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2022.10.028"},{"key":"e_1_3_7_8_2","doi-asserted-by":"publisher","DOI":"10.1097\/MAT.0000000000001652"},{"key":"e_1_3_7_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/vox.12514"},{"key":"e_1_3_7_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.14458"},{"key":"e_1_3_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2021.11.012"},{"key":"e_1_3_7_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3175-1_22"},{"issue":"13","key":"e_1_3_7_13_2","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines","volume":"151","author":"Rao SV","year":"2025","unstructured":"Rao SV, O\u2019Donoghue ML, Ruel M, et al. 2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American college of cardiology\/American heart association joint committee on clinical practice guidelines. Circulation. 2025;151(13):e771-e862.","journal-title":"Circulation"},{"key":"e_1_3_7_14_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198810273191701"},{"key":"e_1_3_7_15_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1996.03540100055028"},{"issue":"2","key":"e_1_3_7_16_2","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0002-8703(99)70118-3","article-title":"A new regimen for heparin use in acute coronary syndromes","volume":"138","author":"Hochman JS","year":"1999","unstructured":"Hochman JS, Wali AU, Gavrila D, et al. A new regimen for heparin use in acute coronary syndromes. Am Heart J. 1999;138(2 Pt 1):313-318.","journal-title":"Am Heart J"},{"key":"e_1_3_7_17_2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.011991"},{"key":"e_1_3_7_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20029"},{"key":"e_1_3_7_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1904"},{"key":"e_1_3_7_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soard.2008.03.005"},{"key":"e_1_3_7_21_2","doi-asserted-by":"publisher","DOI":"10.1177\/08971900221074935"},{"key":"e_1_3_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2014.11.020"},{"key":"e_1_3_7_23_2","doi-asserted-by":"publisher","DOI":"10.1177\/1060028017709819"},{"key":"e_1_3_7_24_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-016-1466-9"},{"key":"e_1_3_7_25_2","doi-asserted-by":"publisher","DOI":"10.4103\/2229-5151.119200"},{"key":"e_1_3_7_26_2","doi-asserted-by":"publisher","DOI":"10.1345\/aph.1P088"},{"key":"e_1_3_7_27_2","doi-asserted-by":"publisher","DOI":"10.1177\/1358863X19875813"},{"key":"e_1_3_7_28_2","doi-asserted-by":"publisher","DOI":"10.1177\/10600280211039582"},{"key":"e_1_3_7_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xjon.2024.11.019"},{"key":"e_1_3_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtha.2022.11.014"},{"issue":"1","key":"e_1_3_7_31_2","first-page":"43","article-title":"Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study","volume":"16","author":"Saito T","year":"2023","unstructured":"Saito T, Hayakawa M, Kumano O, et al. Variation in coagulation factor activity levels cause discrepancies between activated partial thromboplastin time and anti-Xa activity for heparin monitoring: a retrospective observational study. J Intensive Care. 2023;16(1):43.","journal-title":"J Intensive Care"},{"key":"e_1_3_7_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01596.x"}],"container-title":["Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900261417915","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/08971900261417915","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/08971900261417915","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:18:40Z","timestamp":1787494720000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/08971900261417915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,16]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1177\/08971900261417915"],"URL":"https:\/\/doi.org\/10.1177\/08971900261417915","relation":{},"ISSN":["0897-1900","1531-1937"],"issn-type":[{"value":"0897-1900","type":"print"},{"value":"1531-1937","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,16]]}}}